Shaare Zedek Medical Center
Jerusalem, Pob 3235, 91031, Israel
NCT Number: NCT00714402
The purposes of this study are:
1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length 2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever
Looking for future studies?
Notify Me3 day–16 year
All sexes
Observational
Jerusalem, Pob 3235, 91031, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: discharge
Time frame: discharge
Shaare Zedek Medical Center
Other
Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04823026
Bacteremia, Bacterial Infections
Copenhagen, Denmark
View Trial DetailsNCT02979951
Abscess, Bacteremia
Hall in Tirol, Austria
View Trial DetailsNCT05259683
Bacterial Infections, Bacterial Infections and Mycoses
Belfast, Antrim, United Kingdom
View Trial DetailsNCT00366249
Bacterial Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial Details